Tarsus Pharmaceuticals In... (TARS)
45.28
0.95 (2.14%)
At close: Jan 15, 2025, 11:08 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 17.45M | 25.82M | 57.03M | n/a | n/a | n/a |
| Cost of Revenue | 1.59M | 955.00K | 2.08M | 246.00K | 74.00K | 1K |
| Gross Profit | 15.85M | 24.86M | 54.95M | -246.00K | -74.00K | -1K |
| Operating Income | -143.16M | -62.71M | -12.16M | -27.00M | -4.30M | -1.35M |
| Interest Income | 10.34M | 3.50M | 36.00K | 188.00K | 40.00K | n/a |
| Pretax Income | -135.89M | -62.09M | -13.77M | -26.81M | -4.67M | -1.32M |
| Net Income | -135.89M | -62.09M | -13.83M | -26.81M | -4.67M | -1.32M |
| Selling & General & Admin | 108.70M | 44.95M | 25.40M | 8.17M | 1.14M | 449.00K |
| Research & Development | 50.31M | 42.62M | 41.71M | 18.83M | 3.16M | 901.00K |
| Other Expenses | n/a | 86.00K | -73.00K | n/a | n/a | n/a |
| Operating Expenses | 159.01M | 87.57M | 67.11M | 27.00M | 4.30M | 1.35M |
| Interest Expense | 3.35M | 2.20M | n/a | 188.00K | 40.00K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 160.60M | 88.53M | 69.18M | 27.00M | 4.30M | 1.35M |
| Income Tax | n/a | -4.00K | 55.00K | 1K | 1K | 1K |
| Shares Outstanding (Basic) | 29.38M | 24.62M | 20.55M | 20.32M | 19.51M | 4.29M |
| Shares Outstanding (Diluted) | 29.38M | 24.62M | 20.55M | 20.32M | 19.51M | 4.29M |
| EPS (Basic) | -4.62 | -2.52 | -0.67 | -1.32 | -0.24 | -0.31 |
| EPS (Diluted) | -4.62 | -2.52 | -0.67 | -1.32 | -0.24 | -0.31 |
| EBITDA | -131.67M | -59.11M | -13.17M | -26.56M | -4.55M | -1.35M |
| Depreciation & Amortization | 877.00K | 789.00K | 606.00K | 246.00K | 74.00K | 1K |